Posted on:Weil in the News
Weil is advising Covetrus, a global leader in animal-health technology and services, in its $4 billion sale to CD&R, a holder of approximately 24% of Covetrus’ outstanding common stock, and TPG. The transaction is expected to close in the second half of 2022, subject to customary closing conditions.
The Weil team advising Covetrus is led by Mergers & Acquisitions partner Michael J. Aiello and includes Mergers & Acquisitions partners Amanda Fenster and Megan Pendleton, Mergers & Acquisitions counsel Hayden Guthrie and Mergers & Acquisitions associates Iliana Karaoglan, Sarah Grinshtein, Michael Chenkin, Tom Tsatsis and Jack Parsons. The team also includes Tax Head Joseph Pari; Tax associate Grant Solomon; Executive Compensation & Benefits Head Paul Wessel; Executive Compensation & Benefits associate Nate Gross (Not Yet Admitted in New York); Technology & IP Transactions partner Dennis Adams; Technology & IP Transactions/Privacy counsel Olivia Greer; Technology & IP Transactions/Privacy associate Tyler Fredricks; Banking & Finance partner Benton Lewis; Banking & Finance associate Samantha Currie (Admitted in Ontario Only); Antitrust Head Steven Newborn; Antitrust partner Megan Granger; Antitrust counsel Michael Naughton; and Antitrust associate Jarui Wang.